IRCT20200328046886N3招募中3 期
Evaluation of the Efficacy and safety of dolutegravir in patients with moderate COVID-19 disease (randomized double blind placebo controlled trial)
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •1) Aged between 18 to 80
- •2) Patients with definitive diagnosis of covid-19 (Lung involvement in Covid-19 compliant CT confirmed by coronavirus pneumonia).
- •3) =8 days since illness onset
- •4) Having one of the following symptoms: Fever (= 37.8 ° C at any time), Dry cough, Shortness of breath, Fatigue
- •5) One of the following: Involvement of 3 or more lobes of the pulmonary lobes, >O2Sat< 94%
- •6) Patients with signing Informed Consent Form Willing
排除标准
- •1) Severe hepatic impairment (Child-pough C)
- •2) Patients taking Phenytoin, Fosphenytoin, Oxcarbazepine, Phenobarbital, Primidone and St John's Wort
- •3) History of disease because of COVID-19
- •4) History of taking Covid-19 experimental drug
- •5) lactation
- •6) Requires intubation at admission
- •7) Sensitivity to Dolutegravir
- •8) Severe disability that prevents cooperation
- •9) Patient dissatisfaction with the study
研究者
相似试验
进行中（未招募）
1 期
Effectiveness of a dual therapy based on dolutegravir plus lamivudine on reduction of the viral reservoir, immune recovery and immune activation compared with a triple antiretroviral therapy based on dolutegravir plus tenofovir alafenamide/emtricitabine in patients with HIV infection without prior treatment.Adult patients with HIV infection without previous treatmentMedDRA version: 20.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: LLTClassification code 10020160Term: HIV diseaseSystem Organ Class: 10021881 - Infections and infestationsEUCTR2019-000800-14-ESFundación Pública Andaluza para la Gestión en Salud de Sevilla (FISEVI)70
尚未招募
Unknown
Benefits and safety of major medicines in HIV patients.CTRI/2024/04/065522Institute of Medical Sciences, Banaras Hindu University
未知
不适用
Comparison of the efficacy and safety of dulaglutide in combination with insulin compared with insulin alone in daibetes patients who are receiving high dose glucocorticoids therapy: a randomized,open-label trialDiabetes mellitusJPRN-UMIN000020037Kanagawa Cardiovascular and Respiratory Center30
招募中
不适用
Efficacy and safety of dulaglutide in the treatment of type 2 diabetesType 2 diabetes mellitus patientsJPRN-UMIN000027255Department of nephrology, Matsunami general hospital30
已完成
不适用
Safety and efficacy of dulaglutide therapy for the inpatient management of general medicine patients with type 2 diabetesType 2 diabetesJPRN-UMIN000025006Ichinomiyanishi hospital40